Premium
Palforzia for desensitisation of peanut allergy in children
Author(s) -
Chaplin Steve
Publication year - 2021
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1928
Subject(s) - medicine , peanut allergy , dosing , adverse effect , allergy , pediatrics , intensive care medicine , food allergy , immunology , pharmacology
Palforzia is an oral defatted peanut powder licensed for desensitisation of peanut allergy in 4–17 year‐olds. This article discusses the dosing procedure, clinical trial efficacy and adverse effects.